News Coverage | Parker Institute for Cancer Immunotherapy

Research
Network
News
About

Research
Network
- Research Institutions
  Our academic collaborators’ seminal contributions push the field forward
- Directory
  Our constellation of renowned thinkers and partners
- Strategic Partnerships
  The right collaborators across pharma, biotech and nonprofit
- Early Career Researchers
  The next generation of scientific leaders in cancer immunotherapy
News
- News Menu
  - The Latest
    Stories & Announcements
  - News Coverage
    PICI in the News
  - For Media
    Resources for Press
About
- Mission & Vision
  Develop breakthrough immune therapies to turn all cancers into curable diseases faster
- Leadership & Staff
  The driving force behind PICI’s research and operations
- Philanthropic Partners
  Transformative science requires visionary philanthropy
- Careers
  Join us. Change lives.

STAT+

04.28.21

Glowing tumor-munching cells, captured on video, show the promise of a new approach to CAR-T cancer therapy

Read

HemOnc Today

04.23.21

Tumor-infiltrating lymphocytes show ‘provocative’ response rates in advanced melanoma

Read

HemOnc Today

04.16.21

Product composition, immune biomarkers linked to CAR-T efficacy

Read

STAT+

04.12.21

Making a more durable CAR-T

Read

CancerToday

04.05.21

Searching the Blood for Signs of Altered Immunity

Read

Health IT Analytics

04.01.21

$1M Award Will Help Expand COVID-19 Treatment Database

Read

ASH Clinical News

04.01.21

Parker Institute Appoints Ute Dugan as Senior Vice President of Clinical Research

Read

Oncology Times

03.20.21

Dr. Ute Dugan Joins Parker Institute for Cancer Immunotherapy

Read

HemOnc Today

03.13.21

Parker Institute for Cancer Immunotherapy awards research grants

Read

HemOnc Today

03.11.21

Higher disease burden leads to poorer CAR-T outcomes in large B-cell lymphoma

Read

HemOnc Today

03.11.21

Oncologist joins Parker Institute for Cancer Immunotherapy as senior VP

Read

BioSpace

02.16.21

Ute Dugan Joins the Parker Institute for Cancer Immunotherapy as Senior Vice President of Clinical Research

Read